CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8 T Cells.
Immunity
View this publicationImmunity
View this publicationNature chemical biology
View this publicationFEBS letters
View this publicationScience advances
View this publicationCell reports
View this publicationPublication categories: Top publication
Nucleic acids research
View this publicationNature communications
View this publicationNature communications
View this publicationScientific reports
View this publicationMolecular cell
View this publication